Journal of Medicinal Chemistry
Volume 39, Issue 9 (April 26, 1996)
Copyright © 1996
American Chemical Society
1757-1759 | Design and Synthesis of 2',3'-Dideoxy- 2',3'-didehydro- -L-cytidine (-L-d4C) and 2',3'-Dideoxy-2',3'-didehydro--L-5- fluorocytidine (-L-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in Vitro
|
1760-1762 | 2(S)-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3(S)-phenyl-4-((3-oxo-1,2,4-triazol- 5-yl)methyl)morpholine (1): A Potent, Orally Active, Morpholine-Based Human Neurokinin-1 Receptor Antagonist
|
1763-1766 | Methotrexate Resistance of Mouse Dihydrofolate Reductase: Effect of Substitution of Phenylalanine-31 by Serine or Tryptophan
|
1767-1770 | Development of a High Specific Activity Sulfur-35-Labeled Sulfonamide Radioligand That Allowed the Identification of a New Growth Hormone Secretagogue Receptor
|
1771-1777 | Nucleoside Conjugates. 15. Synthesis and Biological Activity of Anti-HIV Nucleoside Conjugates of Ether and Thioether Phospholipids
|
1778-1789 | Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Cyclocymopol Monomethyl Ether
|
1790-1796 | Longimicins A-D: Novel Bioactive Acetogenins from Asimina longifolia (Annonaceae) and Structure-Activity Relationships of Asimicin Type of Annonaceous Acetogenins
|
1797-1805 | Mapping the Melatonin Receptor. 4. Comparison of the Binding Affinities of a Series of Substituted Phenylalkyl Amides
|
1806-1815 | Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic Skeletons
|
1816-1822 | Opioid Antagonist Activity of Naltrexone-Derived Bivalent Ligands: Importance of a Properly Oriented Molecular Scaffold To Guide "Address" Recognition at  Opioid Receptors
|
1823-1835 | Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-Bromophenyl)amino]pyrido[d]- pyrimidines Are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor
|
1836-1845 | Nonclassical 2,4-Diamino-8-deazafolate Analogues as Inhibitors of Dihydrofolate Reductases from Rat Liver, Pneumocystis carinii, and Toxoplasma gondii
|
1846-1856 | Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents
|
1857-1863 | Selective Inhibitors of Monoamine Oxidase. 3. Structure-Activity Relationship of Tricyclics Bearing Imidazoline, Oxadiazole, or Tetrazole Groups
|
1864-1871 | Synthesis and Structure-Activity Relationship of (Lactamylvinyl)cephalosporins Exhibiting Activity against Staphylococci, Pneumococci, and Enterococci
|
1872-1884 | Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors
|
1885-1897 | Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 3. Total Synthesis of (+)-13-Carbaartemisinin and Related Tetra- and Tricyclic Structures
|
1898-1906 | 3,3-Dialkyl- and 3-Alkyl-3-Benzyl-Substituted 2-Pyrrolidinones: A New Class of Anticonvulsant Agents
|
1907-1916 | Synthesis and Anticonvulsant Activities of N-Benzyl-2-acetamidopropionamide Derivatives
|
1917-1923 | 2-(Hydroxyalkyl)estradiols: Synthesis and Biological Evaluation |
1924-1927 | Highly Selective Aldose Reductase Inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic Acids
|
1928-1934 | Synthesis and Pharmacological Properties of Novel 8-Substituted Imidazobenzodiazepines: High-Affinity, Selective Probes for  5-Containing GABAA Receptors
|